{"id":"https://openalex.org/W4386838367","doi":"https://doi.org/10.22270/jddt.v13i9.6222","title":"Pharmacokinetic and Pharmacodynamics Study of Multiple Oral Doses of Vildagliptin Sustained Release 100 Mg Tablets under the Fed State in Healthy Volunteers","display_name":"Pharmacokinetic and Pharmacodynamics Study of Multiple Oral Doses of Vildagliptin Sustained Release 100 Mg Tablets under the Fed State in Healthy Volunteers","publication_year":2023,"publication_date":"2023-09-15","ids":{"openalex":"https://openalex.org/W4386838367","doi":"https://doi.org/10.22270/jddt.v13i9.6222"},"language":"en","primary_location":{"id":"doi:10.22270/jddt.v13i9.6222","doi":"https://doi.org/10.22270/jddt.v13i9.6222","is_oa":true,"landing_page_url":"http://dx.doi.org/10.22270/jddt.v13i9.6222","pdf_url":"https://jddtonline.info/index.php/jddt/article/download/6222/5597","source":{"id":"https://openalex.org/S2764977280","display_name":"Journal of Drug Delivery and Therapeutics","issn_l":"2250-1177","issn":["2250-1177"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://jddtonline.info/index.php/jddt/article/download/6222/5597","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022284997","display_name":"Chetan Doshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chetan Doshi","raw_affiliation_strings":["Chief Scientific Officer, Research and Development, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chief Scientific Officer, Research and Development, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018979803","display_name":"S B Sridhar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"S B Sridhar","raw_affiliation_strings":["Head, Clinical Research, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head, Clinical Research, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048183860","display_name":"Ashish Birla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashish Birla","raw_affiliation_strings":["Vice President, Scientific Services, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vice President, Scientific Services, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031723792","display_name":"Ashish Prasad","orcid":"https://orcid.org/0009-0009-5946-5412","observed_orcids":["https://orcid.org/0009-0009-5946-5412"]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashish Prasad","raw_affiliation_strings":["Asst General Manager, Scientific Services, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asst General Manager, Scientific Services, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109892539","display_name":"Pramod Kadam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pramod Kadam","raw_affiliation_strings":["Manager, Clinical Research, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manager, Clinical Research, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078545136","display_name":"Sona B. Warrier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119848","display_name":"USV (India)","ror":"https://ror.org/02kq47078","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210119848"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sona Warrier","raw_affiliation_strings":["Deputy Manager, USV Private Limited, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deputy Manager, USV Private Limited, Mumbai, India","institution_ids":["https://openalex.org/I4210119848"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210119848"],"apc_list":null,"apc_paid":null,"fwci":0.1733,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44190119,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"13","issue":"9","first_page":"107","last_page":"113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/sustained-release-tablets","display_name":"sustained-release tablets","score":0.8479999899864197},{"id":"https://openalex.org/keywords/immediate-release-tablets","display_name":"immediate release tablets","score":0.9269999861717224},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8019999861717224},{"id":"https://openalex.org/keywords/fed-state","display_name":"fed state","score":0.41100001335144043},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9020000100135803},{"id":"https://openalex.org/keywords/dpp-4-inhibition","display_name":"DPP-4 inhibition","score":0.9580000042915344},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8050000071525574},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.6779999732971191},{"id":"https://openalex.org/keywords/multiple-oral-dosing","display_name":"multiple oral dosing","score":0.6499999761581421},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.7369999885559082},{"id":"https://openalex.org/keywords/drug-formulation-comparison","display_name":"drug formulation comparison","score":0.7129999995231628},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6650000214576721},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.30399999022483826},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.34200000762939453}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9060108661651611},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.896811306476593},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8359984159469604},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7506844997406006},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7243270874023438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.661566972732544},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6462603211402893},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.585839033126831},{"id":"https://openalex.org/C40222840","wikidata":"https://www.wikidata.org/wiki/Q185049","display_name":"Geometric mean","level":2,"score":0.5802837610244751},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4993283748626709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23265016078948975},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.09183847904205322},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.058426082134246826},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.05620455741882324},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22270/jddt.v13i9.6222","doi":"https://doi.org/10.22270/jddt.v13i9.6222","is_oa":true,"landing_page_url":"http://dx.doi.org/10.22270/jddt.v13i9.6222","pdf_url":"https://jddtonline.info/index.php/jddt/article/download/6222/5597","source":{"id":"https://openalex.org/S2764977280","display_name":"Journal of Drug Delivery and Therapeutics","issn_l":"2250-1177","issn":["2250-1177"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery and Therapeutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22270/jddt.v13i9.6222","doi":"https://doi.org/10.22270/jddt.v13i9.6222","is_oa":true,"landing_page_url":"http://dx.doi.org/10.22270/jddt.v13i9.6222","pdf_url":"https://jddtonline.info/index.php/jddt/article/download/6222/5597","source":{"id":"https://openalex.org/S2764977280","display_name":"Journal of Drug Delivery and Therapeutics","issn_l":"2250-1177","issn":["2250-1177"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4323972972","host_organization_name":"Society of Pharmaceutical Tecnocrats","host_organization_lineage":["https://openalex.org/P4323972972"],"host_organization_lineage_names":["Society of Pharmaceutical Tecnocrats"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery and Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386838367.pdf","grobid_xml":"https://content.openalex.org/works/W4386838367.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1972829697","https://openalex.org/W2003221950","https://openalex.org/W2747062154","https://openalex.org/W2949974532","https://openalex.org/W2964440676","https://openalex.org/W2964936333","https://openalex.org/W2996257686","https://openalex.org/W4214592590","https://openalex.org/W4285121117","https://openalex.org/W4311408914","https://openalex.org/W4377098108","https://openalex.org/W4378085752"],"related_works":["https://openalex.org/W4311408914","https://openalex.org/W3128674376","https://openalex.org/W3166394560","https://openalex.org/W4385620701","https://openalex.org/W4214592590","https://openalex.org/W4385967827","https://openalex.org/W2036912696","https://openalex.org/W3186021615","https://openalex.org/W4311406873","https://openalex.org/W2017675780"],"abstract_inverted_index":{"This":[0,38],"study":[1,51,90,278],"evaluated":[2,98,148],"the":[3,9,89,100,103,120,126,165,173,230,261,267,276,290],"pharmacokinetic":[4,96,174,312],"and":[5,154,175,180,195,236,264,304,313,327],"pharmacodynamic":[6,176,314],"profile":[7],"of":[8,88,130,139,190,211,215,243,253,295],"vildagliptin":[10,21,70,81,222,298,305],"100":[11,72,224,300],"mg":[12,23,73,83,225,301,307],"sustained":[13],"release":[14,25],"(SR)":[15],"administered":[16,27],"once":[17,74,302],"daily":[18,29,303],"compared":[19],"to":[20,63,132],"50":[22,82,306],"immediate":[24],"(IR)":[26],"twice":[28,84,308],"in":[30,52,178,319],"healthy,":[31],"adult":[32,54,162,321],"human":[33],"subjects":[34,55,60],"under":[35,56,102,316],"fed":[36,57,317],"conditions.":[37,58],"was":[39,91,99,115,168,198,227,258],"a":[40,66,77],"randomized,":[41],"balanced,":[42],"open-label,":[43],"two-treatment,":[44],"two-period,":[45],"two-sequence,":[46],"crossover":[47],"multiple":[48,247],"oral":[49],"dose":[50],"healthy":[53,161,320],"The":[59,86,94,145,183,208,234,249,292],"were":[61,149,272,287,325],"randomized":[62],"receive":[64],"either":[65],"test":[67,131,181,194,235,262],"product,":[68,79],"i.e.,":[69,80,297],"SR":[71,223,299],"daily,":[75,309],"or":[76,282],"reference":[78,133,179,196,237,268],"daily.":[85],"duration":[87],"25":[92],"days.":[93],"primary":[95],"parameter":[97],"area":[101],"concentration-time":[104],"curve":[105],"for":[106,125,142,193,218],"one":[107],"dosing":[108],"interval":[109],"at":[110],"steady-state":[111],"(AUC0-\u03c4,":[112],"ss).":[113],"Bioequivalence":[114],"determined":[116],"by":[117],"assessing":[118],"whether":[119],"90%":[121,209,241],"confidence":[122],"intervals":[123],"(CIs)":[124],"geometric":[127,212],"mean":[128,184],"ratio":[129,217],"drug":[134],"fell":[135],"within":[136,229],"predefined":[137],"margins":[138],"80%":[140],"\u2212125%":[141],"AUC0-\u03c4,":[143,191,219],"ss.":[144],"pharmacodynamics":[146],"parameters":[147],"percent":[150,157,252],"dipeptidyl-peptidase-4":[151],"(DPP-4)":[152],"inhibition":[153,242,255],"weighted":[155,250],"average":[156,251],"DPP-4":[158,244,254],"inhibition.":[159],"Forty":[160],"males":[163],"completed":[164],"study.":[166,291],"There":[167],"no":[169],"significant":[170],"difference":[171],"between":[172],"profiles":[177,315],"products.":[182],"\u00b1":[185,200,203],"standard":[186],"deviation":[187],"(SD)":[188],"values":[189],"ss":[192,220],"product":[197,238,263],"2689.06":[199],"835.47":[201],"2875.57":[202],"703.85":[204],"ng.":[205],"hr/mL,":[206],"respectively.":[207],"CIs":[210],"least-square":[213],"means":[214],"test/reference":[216],"with":[221,246,260,266],"tablet":[226],"86.32-97.26%":[228],"bioequivalence":[231],"acceptance":[232],"range.":[233],"showed":[239],"over":[240],"activity":[245],"doses.":[248],"(0-24":[256],"hrs)":[257],"92.66%":[259],"93.26%":[265],"product.":[269],"Both":[270,323],"products":[271],"well":[273,328],"tolerated":[274],"during":[275,289],"entire":[277],"period.":[279],"No":[280],"serious":[281],"life-threatening":[283],"adverse":[284],"events":[285],"(AEs)":[286],"reported":[288],"two":[293],"formulations":[294,324],"vildagliptin,":[296],"demonstrated":[310],"similar":[311],"conditions":[318],"males.":[322],"bioequivalent":[326],"tolerated.":[329]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-09-19T00:00:00"}